# A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)

> **NCT01827605** · PHASE3 · UNKNOWN · sponsor: **Fondazione Italiana Linfomi - ETS** · enrollment: 159 (actual)

## Conditions studied

- Relapsed Follicular Lymphoma

## Interventions

- **OTHER:** ZEVALIN
- **DRUG:** BEAM

## Key facts

- **NCT ID:** NCT01827605
- **Lead sponsor:** Fondazione Italiana Linfomi - ETS
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2019-10
- **Final completion:** 2024-01
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2023-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01827605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01827605, "A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT01827605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*